Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The pterocarpan (+)-PTC modulates cytoskeletal proteins and induces apoptosis in metastatic castration-resistant prostate cancer: a proteomic perspective.

Frontiers in pharmacology·2026
Same author

Protein-protein interactions in Escherichia coli: Using cross-linking/mass spectrometry (XLMS) to reveal our current knowledge gaps in interactomes.

Journal of proteomics·2026
Same author

Impact of leucine-rich diet on placenta's proteomic and metabolomic profiles of pregnant tumor-bearing rats.

Cancer biology & therapy·2026
Same author

Unraveling the Antimicrobial and Antibiofilm Activity of Ag-phendione and Cu-phendione Against Multidrug-resistant Klebsiella pneumoniae Using Shotgun Proteomics.

Current topics in medicinal chemistry·2026
Same author

Editorial: The impact of proteomics on understanding inflammatory and infectious diseases.

Frontiers in immunology·2026
Same author

Plasma Proteomic Profile of Chemotherapy-Induced Severe Neutropenia: A Pilot Discovery Phase Study.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026

Related Experiment Video

Updated: Nov 6, 2025

Characterization and Isolation of Mouse Primary Microglia by Density Gradient Centrifugation
10:21

Characterization and Isolation of Mouse Primary Microglia by Density Gradient Centrifugation

Published on: February 16, 2018

19.7K

DIA-MSE to Study Microglial Function in Schizophrenia.

Guilherme Reis-de-Oliveira1, Victor Corasolla Carregari1, Daniel Martins-de-Souza2,3,4,5

  • 1Lab of Neuroproteomics, Department of Biochemistry and Tissue Biology, Institute of Biology, University of Campinas (UNICAMP), Campinas, Brazil.

Methods in Molecular Biology (Clifton, N.J.)
|May 5, 2021
PubMed
Summary
This summary is machine-generated.

Researchers developed a proteomic pipeline using human microglial cells to model schizophrenia. This method enhances proteome coverage for studying the complex disease, schizophrenia.

Keywords:
DIAMSEMass spectrometryMicrogliaSchizophreniaUDMSE

More Related Videos

Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain
10:40

Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain

Published on: October 27, 2019

33.8K
In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma
12:48

In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma

Published on: May 11, 2015

10.8K

Related Experiment Videos

Last Updated: Nov 6, 2025

Characterization and Isolation of Mouse Primary Microglia by Density Gradient Centrifugation
10:21

Characterization and Isolation of Mouse Primary Microglia by Density Gradient Centrifugation

Published on: February 16, 2018

19.7K
Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain
10:40

Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain

Published on: October 27, 2019

33.8K
In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma
12:48

In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma

Published on: May 11, 2015

10.8K

Area of Science:

  • Neuroscience
  • Proteomics
  • Cell Biology

Background:

  • Schizophrenia is a complex neurological disorder with poorly understood molecular mechanisms.
  • Human microglial cells play a crucial role in brain immunity and are implicated in schizophrenia pathogenesis.
  • Existing proteomic approaches may have limitations in comprehensive coverage of the microglial proteome.

Purpose of the Study:

  • To establish and validate a robust proteomic pipeline for studying schizophrenia using a human microglial cell line.
  • To maximize proteome coverage in microglial cells for identifying disease-relevant proteins.
  • To optimize mass spectrometry acquisition parameters for enhanced biological insights.

Main Methods:

  • Utilized a human microglial cell line as a biological model for schizophrenia research.
  • Employed two-dimensional liquid chromatography (2D-LC) for enhanced peptide separation.
  • Applied ultra-definition MSE mass spectrometry (UDMSE) with a data-independent acquisition (DIA) strategy.
  • Optimized drift time collision energy parameters to improve proteome coverage.

Main Results:

  • The developed pipeline achieved extensive proteome coverage in the human microglial cell line.
  • The data-independent acquisition (DIA) approach, coupled with optimized parameters, proved effective for comprehensive protein identification.
  • This methodology provides a foundation for in-depth proteomic analysis of schizophrenia.

Conclusions:

  • The described proteomic pipeline offers a powerful tool for investigating the molecular underpinnings of schizophrenia.
  • The use of human microglial cells and advanced LC-UDMSE DIA mass spectrometry enhances the study of neurological disorders.
  • This approach facilitates the identification of novel biomarkers and therapeutic targets for schizophrenia.